Schuylkill Financial’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$982K Sell
9,770
-248
-2% -$25.4K 0.96% 26
2026
Q2
$992K Buy
+10,018
New +$903K 0.92% 28

Other funds holding IHE

Schuylkill Financial's IHE Position: Q3 2026 in Review

Schuylkill Financial reduced its iShares US Pharmaceuticals ETF (IHE) stake by 2.5% in Q3 2026, selling an estimated $25.4K and leaving 9,770 shares worth $982K. The position accounts for 0.96% of the portfolio, ranked #26.

Schuylkill Financial first reported a position in IHE in Q2 2026 and has held it in 2 quarters since. The position peaked at $992K in Q2 2026. 248 funds tracked by Wall St. Rank hold IHE as of Q3 2026.

  • Schuylkill Financial held 9,770 shares of iShares US Pharmaceuticals ETF worth $982K as of Q3 2026.
  • Schuylkill Financial sold 248 iShares US Pharmaceuticals ETF shares in Q3 2026, an estimated $25.4K.
  • iShares US Pharmaceuticals ETF made up 0.96% of Schuylkill Financial's portfolio in Q3 2026, its #26 holding.
  • Schuylkill Financial first reported a position in iShares US Pharmaceuticals ETF in Q2 2026 and has held it in 2 quarters since.
  • Schuylkill Financial's iShares US Pharmaceuticals ETF position peaked at $992K in Q2 2026.
  • 248 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2026.

Based on Schuylkill Financial's 13F filing for Q3 2026, filed 21 Oct 2026.